In the last trading session, 1.03 million shares of the Leap Therapeutics Inc (NASDAQ:LPTX) were traded, and its beta was 0.32. Most recently the company’s share price was $0.51, and it changed around $0.01 or 1.78% from the last close, which brings the market valuation of the company to $19.50M. LPTX currently trades at a discount to its 52-week high of $4.79, offering almost -839.22% off that amount. The share price’s 52-week low was $0.48, which indicates that the current value has risen by an impressive 5.88% since then. We note from Leap Therapeutics Inc’s average daily trading volume that its 10-day average is 2.46 million shares, with the 3-month average coming to 734.55K.
Leap Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 2 recommended LPTX as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Leap Therapeutics Inc is expected to report earnings per share of -0.38 for the current quarter.
Leap Therapeutics Inc (NASDAQ:LPTX) trade information
Instantly LPTX has showed a green trend with a performance of 1.78% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.5568 on recent trading dayincreased the stock’s daily price by 8.41%. The company’s shares are currently down -82.30% year-to-date, but still down -9.12% over the last five days. On the other hand, Leap Therapeutics Inc (NASDAQ:LPTX) is -85.37% down in the 30-day period. We can see from the shorts that 1.01 million shares have been sold at a short interest cover period of 2.68 day(s).
The consensus price target as assigned by Wall Street analysts is $5.5, which translates to bulls needing to increase their stock price by 90.73% from its current value. Analyst projections state that LPTX is forecast to be at a low of $5.5 and a high of $5.5.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 28.36%. Leap Therapeutics Inc earnings are expected to increase by 53.39% in 2025, but the outlook is positive 32.44% per year for the next five years.
LPTX Dividends
Leap Therapeutics Inc’s next quarterly earnings report is expected to be released in March.
Leap Therapeutics Inc (NASDAQ:LPTX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 17.29% of Leap Therapeutics Inc shares, and 40.30% of them are in the hands of institutional investors. The stock currently has a share float of 48.73%.
